Format

Send to

Choose Destination
Immunol Lett. 2004 May 15;93(2-3):115-22.

Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever.

Author information

1
Unidad de Investigación Médica en Inmunoquímica, 1er piso Hospital de Especialidades, Centro Médico National Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), P.O. Box A-047, C.P. 06703 México DF, México.

Abstract

Typhoid fever remains a serious public health problem. We have developed a vaccine from Salmonella enterica serovar typhi (S. typhi) outer-membrane proteins (OMPs) known as porins. A single subcutaneous dose of 10 microg of porins induced a five-fold (P = 0.05) seroconversion index consisting of IgM and IgG at 7 and 15 days after vaccination as well as the production of IgG1 and IgG2 isotypes. The porins-based vaccine induced a two-fold increase (P = 0.05) in bactericidal titres in volunteers, whom also developed a T-cell response characterized by the production of interferon-gamma (INF-gamma). Side effects after vaccination were mild and transient. The data showed that our S. typhi porins-based candidate vaccine is safe and immunogenic in healthy humans.

PMID:
15158606
DOI:
10.1016/j.imlet.2004.01.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center